Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Myositis
ADR ID BADD_A02949
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.05      Muscle disorders
15.05.01      Muscle infections and inflammations
15.05.01.001      Myositis
Description A disorder characterized by inflammation involving the skeletal muscles. [CTCAE] Inflammation of a muscle or muscle tissue. [MeSH]
MedDRA Code 10028653
MeSH ID D009220
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Interstitial myositis | Muscle inflammation | Myalgia and myositis, unspecified | Myositis | Granulomatous myositis | Myotenositis | Myositides | Myopathy, Inflammatory | Muscle Diseases, Inflammatory | Inflammatory Muscle Diseases | Inflammatory Muscle Disease | Muscle Disease, Inflammatory | Inflammatory Myopathy | Inflammatory Myopathies | Myopathies, Inflammatory | Myositis, Proliferative | Myositides, Proliferative | Proliferative Myositides | Proliferative Myositis | Myositis, Infectious | Infectious Myositides | Myositides, Infectious | Infectious Myositis | Idiopathic Inflammatory Myopathies | Myopathy, Idiopathic Inflammatory | Inflammatory Myopathy, Idiopathic | Idiopathic Inflammatory Myopathy | Idiopathic Inflammatory Myositis | Inflammatory Myopathies, Idiopathic | Myopathies, Idiopathic Inflammatory | Myositis, Focal | Focal Myositides | Focal Myositis | Myositides, Focal
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02047Sodium oxybate0.000268%
BADD_D02099Sumatriptan succinate--
BADD_D02105Tacrolimus0.000802%
BADD_D02145Telbivudine--
BADD_D02147Telmisartan--
BADD_D02154Tenofovir0.001939%
BADD_D02160Terbinafine0.000149%
BADD_D02214Ticagrelor0.001061%
BADD_D02215Ticlopidine--
BADD_D02216Ticlopidine hydrochloride--
BADD_D02227Tipranavir disodium--
BADD_D02236Tofacitinib0.002363%
BADD_D02257Trametinib0.000112%
BADD_D02270Tretinoin0.000213%
BADD_D02331Valsartan--
BADD_D02337Varenicline--
BADD_D02338Varenicline tartrate--
BADD_D02365Vismodegib0.000112%
BADD_D02378Zalcitabine--
BADD_D02379Zaleplon--
BADD_D02381Ziconotide--
BADD_D02383Zidovudine--
BADD_D02412Octreotide--
BADD_D02436Atorvastatin0.000037%
BADD_D02463Pitavastatin0.001401%
BADD_D02470Nintedanib0.000224%
BADD_D02480Alectinib0.000358%
BADD_D02577Oseltamivir acid0.000545%
The 5th Page    First    Pre   5    Total 5 Pages